Table 1. Antibacterial activity results of E. aphylla extract and nanomaterials against various pathogenic bacteria.
| Microorganisms | Inhibition zones in mm | |||
|---|---|---|---|---|
| E. aphylla extract | Ag-TiO2 NC | Ag-SeO2 NC | Gentamycin | |
| Gram-negative bacteria | ||||
| Escherichia coli (ATCC 10536) | −ve | −ve | 30.0 ± 1.20 | 17.0 ± 1.29 |
| Salmonella typhimurium (ATCC 25566) | −ve | −ve | 30.0 ± 1.88 | 14.0 ± 1.81 |
| Klebsiella pneumonia (ATCC 10031) | −ve | 15.6 ± 1.43 | 31.0 ± 1.27 | 16.0 ± 1.03 |
| Enterobacter cloacae (DMS 30054) | −ve | −ve | 11.0 ± 1.35 | 14.0 ± 1.35 |
| Gram-positive bacteria | ||||
| Bacillus subtilis (DMS 1088) | −ve | −ve | 44.0 ± 1.09 | 17.0 ± 1.41 |
| Bacillus cereus (EMCC number 1080) | −ve | 14 | 12.0 ± 1.16 | 21.0 ± 1.56 |
| Staphylococcus aureus (ATCC 6538) | 17.0 ± 1.58 | 15.3 ± 1.06 | 31.0 ± 1.72 | 15.0 ± 1.90 |
| Staphylococcus epidermidis (EMCC number 1353 t) | 12.0 ± 1.59 | −ve | 11.0 ± 1.34 | 17.0 ± 1.14 |